Biographical Sketch
Robert Fox, MD, is Staff Neurologist and Medical Director at the Mellen Center for Multiple Sclerosis at Cleveland Clinic. He received his medical degree from Johns Hopkins University, neurology residency training at the University of Pennsylvania, and a master’s degree in Clinical Research from Case Western Reserve University.
He serves as an advisory committee member and principal site investigator for many clinical trials, including coordinating principal investigator for a Phase III clinical trial of fumarate in relapsing remitting Multiple Sclerosis (MS).
Dr. Fox’s current research interests focus on innovative MRI techniques to evaluate MS treatments and tissue recovery after injury, where he is principal investigator and co-investigator on grants funded by the NIH and National MS Society. He serves as a member of various advisory and review committees for the National MS Society. He is also a member of the General Advisory Council for the Cleveland Clinic General Clinical Research Center, and he is a consultant to the pharmaceutical industry regarding the development of new treatments for MS.
Specialty Interests
Multiple Sclerosis, Neuroimmunology
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 7/30/2008, Dr.
Fox has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Fox receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Biogen Idec
MEDACorp, Inc.
